Real Chemistry Acquires conversationHEALTH
Real Chemistry, a health innovation company, has acquired conversationHEALTH, providers of a conversational artificial intelligence (AI) platform for the healthcare and life sciences industry. Financial terms of the deal were not disclosed.
"In the new digital-first world, healthcare professionals, patients, and consumers are now engaging with global life sciences companies in new ways with the expectation of 24/7/365 accessibility and a personalized, digital experience," said Shankar Narayanan, CEO of Real Chemistry, in a statement. "The acquisition of conversationHEALTH brings best-in-class conversational AI technologies and medical expertise to help our clients deliver medical interaction at scale, through text, voice, and digital humans, across markets and languages."
conversationHEALTH joins Real Chemistry's Data and Artificial Intelligence Solutions group, which includes Swoop, a provider of AI-generated digital audiences for precision marketing, and IPM.ai.
"Patients and consumers want the same kind of access and personalized interaction in health that they have in other areas of their digital lives. We've built sophisticated AI-powered virtual assistants to augment and virtualize human teams in order to meet these needs at scale, cost-effectively and compliantly," said Dr. John Reeves, founder and CEO of conversationHEALTH, in a statement. "Combining forces with Real Chemistry provides conversationHEALTH with access to deep AI expertise, additional deployment resources, and client opportunities to fuel our innovation and growth."